Cellular senescence checkpoint function determines differential Notch1-dependent oncogenic and tumor-suppressor...

Area of Science:

• Oncology
• Cell Biology
• Molecular Biology

Background:

• Notch signaling's role in tumor biology is complex and context-dependent, acting as both an oncogene and tumor suppressor.
• The interplay between Notch signaling and cellular senescence checkpoints is not well understood.
• Investigating this interaction is crucial for understanding tumor development and potential therapeutic strategies.

Purpose of the Study:

• To delineate the functional consequences of Notch activation and inhibition in esophageal cancer.
• To explore the interaction between Notch signaling and cellular senescence pathways.
• To elucidate the role of Notch1 in oncogenesis and tumor suppression within the context of senescence.

Main Methods:

• Utilized genetically engineered human esophageal keratinocytes and esophageal squamous cell carcinoma cells.
• Employed tetracycline-inducible expression of activated Notch1 (ICN1).
• Conducted pharmacological interventions and RNA interference experiments, including assessing p16INK4A and human papillomavirus (HPV) E6/E7 oncogene products.

Main Results:

• Ectopic expression of activated Notch1 (ICN1) induced cellular senescence, characterized by G0/G1 cell-cycle arrest, Rb dephosphorylation, and senescence-associated β-galactosidase activity.
• Notch-induced senescence involves CSL/RBPJ transcriptional activity and the p16INK4A-Rb pathway.
• Loss of p16INK4A or presence of HPV E6/E7 prevented Notch1-induced senescence, promoting anchorage-independent growth, xenograft tumor formation, and reduced differentiation, highlighting Notch1's tumor-suppressor role.

Conclusions:

• Cellular senescence checkpoints significantly influence the dichotomous roles of Notch signaling in cancer.
• Notch1 acts as an oncogene by inducing senescence but functions as a tumor suppressor when inactivated by viral oncogenes like HPV E6/E7.
• Understanding these context-dependent activities is key to targeting Notch signaling in esophageal cancer therapy.